Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 265-182-8 | CAS number: 64742-79-6 A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230°C to 400°C (446°F to 752°F).
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
No relevant infrmation available. A testing proposal has been submitted for an extended one-generation study
Effect on fertility: via oral route
- Endpoint conclusion:
- no study available
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available (further information necessary)
Additional information
Study proposal to fulfil the information requirements of REACH Annex IX (8.7.3). In a number of repeat dose (dermal) and several OECD 414 developmental toxicity studies there were no effects observed on development. In addition, no effects were observed on reproductive organs in subchronic studies with OGO and an assessment of the overall weight of evidence (as outlined in the attached testing proposal) concludes that it is unlikely that the primarily aliphatic OGOs have an adverse effect on fertility.
No guideline studies were located that have examined the potential impact of Other Gas Oils on reproductive function. Some indication of the likely effect of a test substance on reproductive organs can be gained from the results of repeated-dose toxicity studies with members of this category, which did not show any treatment related effects on reproductive (Table 1). Nevertheless, a testing proposal for an extended one-generation study with a representative sample for the category is included.
Table 1. Summaries of data on reproductive organs from subchronic studies with OGO (Robust study summaries are provided in IUCLID Section 7.5 Repeated Dose Toxicity) |
||||
Test Material |
Route, Species, Doses, Exposure Regimen |
Endpoints |
Results |
Reference |
API 81-09 Hydrodesulfurized middle distillate CAS 64742-80-9 |
Inhalation. Rat. 23 mg/m3, 6 hr/day, 5 days/wk, 4 wk |
Weight of ovaries and testes. Histopathology of ovary, uterus, prostate, and testis. |
No treatment-related effect except for “variation” in “absolute and/or relative” weight of testis. Body weight was unaffected. No further details were in summary report for Group III. |
API, 1986 |
API 81-09 Hydrodesulfurized middle distillate CAS 64742-80-9 |
Dermal. Rabbit. 200, 1000, or 2000 mg/kg/day, 3 days/wk, 4 wk |
Weight of ovaries and testes. Histopathology of ovaries, vagina, uterus, testes, epididymides, prostate, and seminal vesicles. |
No observed treatment-related effect on reproductive organs. |
API, 1983 |
Short description of key information:
Study proposal to fulfill the information requirements of REACH Annex IX (8.7.3) with respect to reproductive toxicity. In a number of repeat dose (dermal) and several OECD 414 developmental toxicity studies there were no effects observed on development. In addition, no effects were observed on reproductive organs in sub chronic studies with OGO and an assessment of the overall weight of evidence (as outlined in the attached testing proposal) concludes that it is unlikely that the primarily aliphatic OGOs have an adverse effect on fertility.
Effects on developmental toxicity
Description of key information
In a read across developmental study from a straight-run petroleum gas oil, authors reported a NOAEL of 50 mg/kg body weight/day, based on significant decrease in pup body weight and increase in external, visceral, and skeletal malformations at a dose of 250 mg/kg body weight/day. The maternal LOAEL was 50 mg/kg body weight/day, based on dermal effects. It is concluded that there is no evidence of developmental toxicity in the absence of significant maternal toxicity.
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- NOAEL
- 50 mg/kg bw/day
Additional information
No studies were located for OGO substances. However information from a dermal study in rats on a Straight-run gas oil (straight-run petroluem gas oil; CAS 64741 -43 -1) may be used as a source of information for read across. Straight run gas oil data can be used as read-across data for OGO substances due to similar physical/chemical properties and composition.
In a key read across, developmental toxicity study (ARCO, 1993a), straight-run petroleum gas oil (F-193) in acetone was dermally administered to 25 presumed pregnant rats/dose at dose levels of 0, 50, 250, or 500 mg/kg bw/day from days 0 through 19 of gestation.
Skin reactions (erythmea, oedema, atonia, and desquamation) occurred in all treatment groups. There was a significant reduction in body weight and feed consumption in the 250 - and 500 -mg/kg/day groups. There was also a significant reduction in average litter size and live foetuses, increased resorptions in these groups.
The maternal LOAEL was 50 mg/kg/day, based on dermal effects. There was no maternal NOAEL. There was a significant decrease in pup body weight and increase in external, visceral, and skeletal malformations in the mid- and high-dose groups.The developmental LOAEL was 250 mg/kg/day, based on pup body weight and malformations. The developmental NOAEL was 50 mg/kg/day.
Justification for classification or non-classification
No reproductive toxicity data are available for other gas oils so there is insufficient information to classify this category as toxic for reproduction under the EU CLP Regulation (EC No. 1272/2008). An extended one-generation reproductive toxicity study is proposed for a representative sample of the category
A key read-across developmental study on a sample of a straight run gas oil was identified. The LOEL for maternal toxicity was 50 mg/kg based on local dermal effects. The NOAEL for foetal toxicity was 50mg/kg. No classification for effects on development is proposed however since there was no evidence of foetal effects in the absence of significant maternal toxicity.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.